retatrutide efficacy weight loss with as compared to currently licenced obesity BioCentury - Retatrutide data strengthen

Short-acting GLP-1 receptor agonists include immediate-release exenatide (Byetta) with a half-life of approximately 2.4 hours

In clinical trials, participants reported eating 30 to 50% less than their pre treatment amounts without conscious effort

People who follow a specific tirzepatide diet plan often find that timing their injection after their largest meal minimizes GI discomfort

Dedicate half of your plate to non-starchy vegetables, which are packed with fiber and nutrients

The post also flags personal history of pancreatitis as an important contraindication to assess during the initial evaluation

Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients